UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Cash flows provided by (used in) operating activities:
Net income (loss)	$ 125,864	$ 833,080
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Net realized (gains) losses on investments	(96,267)	(75,519)
Net realized and unrealized (gains) losses on derivative instruments	(18,540)	(3,660)
Amortization of premiums (discounts) on fixed maturities	118,021	127,524
(Income) loss from investment and operating affiliates	(107,659)	(172,256)
Loss on sale of life reinsurance subsidiary	666,423	0
Share-based compensation	65,304	45,447
Depreciation	43,511	44,147
Accretion of deposit liabilities	3,136	36,779
Changes in:
Unpaid losses and loss expenses	(128,919)	(85,471)
Future policy benefit reserves	(172,234)	(128,281)
Funds withheld on life retrocession agreements, net	2,968	0
Unearned premiums	524,393	486,249
Premiums receivable	(262,435)	(341,520)
Unpaid losses and loss expenses recoverable	(230,870)	28,566
Ceded unearned premiums	(251,985)	(183,198)
Reinsurance balances receivable	(49,462)	(38,612)
Deferred acquisition costs	243,391	(47,859)
Reinsurance balances payable	264,994	338,769
Deferred tax asset - net	(42,142)	(3,693)
Derivatives	(6,262)	14,563
Other assets	(44,467)	(81,148)
Other liabilities	(154,501)	39,645
Other	16,953	19,337
Total adjustments	602,161	19,809
Net cash provided by (used in) operating activities	728,025	852,889
Cash flows provided by (used in) investing activities:
Proceeds from sale of fixed maturities and short-term investments	4,048,233	3,042,348
Proceeds from redemption of fixed maturities and short-term investments	2,681,001	3,142,738
Proceeds from sale of equity securities	370,189	95,083
Purchases of fixed maturities and short term investments	(5,616,992)	(6,480,368)
Purchases of equity securities	(326,319)	(358,484)
Proceeds from sale of affiliates	231,902	194,956
Purchases of affiliates	(293,974)	(289,716)
Proceeds from sale of life reinsurance subsidiary	570,000	0
Other, net	(158,250)	83,575
Net cash provided by (used in) investing activities	1,505,790	(569,868)
Cash flows provided by (used in) financing activities:
Proceeds from issuance of ordinary shares and exercise of stock options	5,411	9,718
Buybacks of ordinary shares	(626,774)	(525,520)
Dividends paid on ordinary shares	(129,490)	(121,131)
Distributions to non-controlling interests	(41,463)	(42,026)
Contributions from non-controlling interests	24,839	500
Repayment of debt	600,000	0
Deposit liabilities	(266,542)	(87,788)
Net cash provided by (used in) financing activities	(1,634,019)	(766,247)
Effects of exchange rate changes on foreign currency cash	(46,894)	(4,259)
Increase (decrease) in cash and cash equivalents	552,902	(487,485)
Cash and cash equivalents beginning of year	1,800,832	2,618,378
Cash and cash equivalents end of year	2,353,734	2,130,893
Life Funds Withheld Assets
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Net realized (gains) losses on investments	13,619	0
Net realized and unrealized (gains) losses on derivative instruments	$ 218,810	$ 0